We are live on
!
Find out more
1WCM
12 West Capital Management Portfolio holdings
AUM
$592M
1-Year Est. Return
40.75%
This Fund
S&P 500
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+40.75%
3 Year Est. Return
+135.85%
5 Year Est. Return
+71.32%
10 Year Est. Return
+854.35%
AUM
$1.13B
AUM Growth
-$40.2M
(-3.4%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
1.21%
Top 10 Holdings %
Top 10 Hldgs %
84.23%
Holding
23
New
1
Increased
5
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$26.6M |
| 2 |
Toast
TOST
|
+$25.3M |
| 3 |
AppFolio
APPF
|
+$22.3M |
| 4 |
Bio-Techne
TECH
|
+$18.2M |
| 5 |
Roblox
RBLX
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$56.5M |
| 2 |
nCino
NCNO
|
+$12.4M |
| 3 |
Affirm
AFRM
|
+$8.13M |
| 4 |
Sprout Social
SPT
|
+$6.61M |
| 5 |
GDS Holdings
GDS
|
+$5.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 60.44% |
| 2 | Healthcare | 15.43% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Communication Services | 9.69% |
| 5 | Financials | 0% |
Similar funds
AIP
CAMV
MPW
LBIM
SM
MW
DPRC
BBL
12 West Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, 12 West Capital Management held 23 positions worth $1.13B, down 3.4% from $1.17B the previous quarter. Its ten largest holdings account for 84% of the portfolio.
12 West Capital Management's Q3 2022 filing shows 1 new, 5 increased, 5 reduced and 3 closed positions. Its largest new stake was Bio-Techne: 210,592 shares worth $15M. The largest sale was 10x Genomics, an estimated $56.5M.
By sector, the portfolio is most concentrated in Technology at 60% of assets, up from 60% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 12 West Capital Management's largest Q3 2022 buy was Bio-Techne: 210,592 shares worth $15M.
- 12 West Capital Management added most to Smartsheet Inc. in Q3 2022, an estimated $26.6M increase.
- 12 West Capital Management's biggest Q3 2022 reduction was Sprout Social, cutting an estimated $6.61M.
- 12 West Capital Management fully exited 10x Genomics in Q3 2022, selling an estimated $56.5M.
- 12 West Capital Management's ten largest holdings make up 84% of its $1.13B portfolio in Q3 2022.
- 12 West Capital Management opened 1 new position and closed 3 in Q3 2022.
- 12 West Capital Management's portfolio value fell 3.4% quarter-over-quarter to $1.13B.
Based on 12 West Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.